Brian Burke Email & Phone Number

Bedford, Bedfordshire, GB

Bedford, Bedfordshire, GB

Solihull, GB

Solihull, GB

Solihull, GB

Rehovot, Israel, IL

• Chair of Horizon's Executive Leadership Team as well as a member of the PerkinElmer Life Sciences Strategy Team.
• Accountable for delivery of the strategic review with P&L responsibility, working with the BU management across the business, gaining Board approval for 2018 and 2019 Strategic Reviews (5-year plans).
• As Corporate lead, scope and deliver all merger & acquisition (M&A) activity including divestments (deal origination through to deal closure and advisor to the Board on monthly pipeline and deal progress).
• Creation of a corporate development team to focus specifically on therapeutic out-licensing of Horizon’s ground breaking enabling technologies to companies producing gene and cell therapies
• Position Horizon as a market leader for gene editing with novel Cas enzymes beyond Cas9 to improve competitive advantage.

Cambridge, Cambridgeshire, GB

• Evolution and expansion of Head of Business Management role to give greater support to Executive Function following the exit of the founder CEO, which marked the start of a new era at Horizon.
• Maintained trust and credibility by careful stakeholder management to support significant change.
• Hired and developed a new Head of Product Management to accelerate Horizon’s portfolio management and competitive trajectory.
• Successfully delivered multi million-pound licensing revenue with major partners in the bioprocessing field.

Cambridge, Cambridgeshire, GB

• Lead role in the commercial team during a period of business transformation.
• Direct accountability for all Product Management and Field Applications (14 FTE), merging 3 diverse product management teams, each distinct by market and geographical base (Cambridge, St Louis, LaFayette).
• Delivered a review of company wide product/services portfolio including strategy recommendations.
• Identified and delivered key projects for Horizon with key multinational partners to provide technology enablement and further business growth.
• Member of the due diligence team for the acquisition of Dharmacon.

Cambridge, Cambridgeshire, GB

• Driving sales and business development success across multiple teams for Horizon focusing on Diagnostics, Cell Line Products and Bioproduction Business Units. Assumed responsibility for Product Management mid 2016.
• Enhanced front line Commercial Team by recruiting and line managing a team of eleven sales and business development professionals from initial headcount of two.

Cambridge, Cambridgeshire, GB

• Delivered integrated performance for Products Division including Diagnostics, Cell Line Products and Bioproduction Business Units.
• Implemented changes that supported significant and consistent growth in Diagnostics business.
• Line managed business development and sales teams for Products Division reporting to one of the Horizon’s commercial founders.
• Achieved the commercial launch of Bioproduction by securing a multi year project jointly with top 3 Pharma & CMO to develop single site integration technology with pending multi-million pound licensing opportunities.
• Secured key grant collaborations and matched grant funding for Bioproduction and Diagnostics, allowing Horizon to pursue ambitious and targeted product development while significantly raising the company profile.

Cambridge, Cambridgeshire, GB

• Built new business principally around Molecular Reference Standards for the Oncology Diagnostics market.
• Established transactional sales model scalable for e-commerce through direct business in Europe and USA with distribution in Japan and also Italy.
• Launched highly innovation NGS products for oncology screening resulting in significant sales and winning an award from The Scientist.

St. Louis, MO, US

• Global role as part of a senior team reporting to the Corporate HQ in St Louis, focused on new product commercialisation, specifically the sourcing, commercial evaluation and launch of new products.
• Managed global deal making for in-licensing, out-licensing and OEM through cross functional team leadership including a multi-million dollar agreement to distribute all ECACC cell lines globally excluding Japan and.
• Exposure to corporate M&A processes including formal training from ideation to execution.
• Role expanded to include ZFN out-licensing for Bioproduction in late 2011. This resulted in the first bioproduction out-licensing deal for Sigma.

St. Louis, MO, US

• Provided strong leadership of Field Sales Group across Custom and Functional Genomics portfolio in the UK and Ireland.
• Positioned as the commercial and technical lead, including gene editing.Created new benchmarks for the UK team for siRNA, shRNA and ZFN sales.
• Recruited and led a new internal sales team, managing this group to exceed budget.

US

Senior sales role focused on medium value custom genomics projects. Delivered sales in Northern Europe while maintaining key accounts in the UK. Successfully launched first NGS Service based on 454 FLX platform.

US

Service based sales role focused on sequencing, microarrays, genotyping and QPCR including research and GLP product offerings.

Leeds, West Yorkshire, GB

Selected as Yorkshire Forward’s first Bioscience Yorkshire Enterprise Fellow, a role which afforded the opportunity to move academic science beyond the laboratory and towards market.

Leeds, West Yorkshire, GB

Phd, Biochemistry

Education record